It was shown that monocytes from healthy subjects are able to acquire the phenotype and suppressive function of M-MDSCs under exposure to cancer cells and the specific microenvironment with a high level of interleukin 10 (IL-10) or prostaglandin E2 (PGE2). The gene discussed is IL10; the disease is cancer.